Cleared Traditional

K943571 - MULTI-LEVEL CONTROL FOR FIBRIN DEGRADATION PRODUCTS

K943571 is an FDA 510(k) clearance for MULTI-LEVEL CONTROL FOR FIBRIN DEGRADAT..., manufactured by More Diagnostics. The device is a Class 2 Hematology device with product code DAP cleared through the Traditional 510(k) pathway after a 331-day FDA review.

K943571 · More Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1995
Decision
331d
Days
Class 2
Risk

K943571 is an FDA 510(k) clearance for the MULTI-LEVEL CONTROL FOR FIBRIN DEGRADATION PRODUCTS. Classified as Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control (product code DAP), Class II - Special Controls.

Submitted by More Diagnostics (Los Osos, US). The FDA issued a Cleared decision on June 15, 1995 after a review of 331 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7320 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all More Diagnostics devices

FDA 510(k) Submission Details - K943571

510(k) Number K943571 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 19, 1994
Decision Date June 15, 1995
Days to Decision 331 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
218d slower than avg
Panel avg: 113d · This submission: 331d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DAP Device Classification - Class 2, Special Controls

Product Code DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - DAP Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control

All 50
Devices cleared under the same product code (DAP) and FDA review panel - the closest regulatory comparables to K943571.
IL TEST D-DIMER
K972696 · Instrumentation Laboratory CO · Nov 1997
STA-LIATEST D-DI TEST KIT
K964728 · American Bioproducts Co. · Jun 1997
STA D-DI CALIBRATOR KIT
K964718 · American Bioproducts Co. · May 1997
AURATEK FDP
K943787 · Organon Teknika Corp. · Sep 1994
FIBRIN(OGEN) FDP CONTROL LEVEL 1 & LEVEL 2
K932657 · More Diagnostics · Nov 1993
FIBRINOSTIKA TDP MICROELISA SYSTEM
K915698 · Organon Teknika Corp. · Aug 1992